GS
KYTH

George Soros’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

George Soros’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-54,194
Closed -$2.72M – 314
2015
Q1 		$2.72M Buy
+54,194
New +$2.27M 0.03% 183

Other funds holding KYTH

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WIC
Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

George Soros's KYTH Position: Q2 2015 in Review

George Soros sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q2 2015, closing a stake of 54,194 shares — an estimated $2.72M sold.

George Soros first reported a position in KYTH in Q1 2015 and held it in 1 quarter. The position peaked at $2.72M in Q1 2015. 153 funds tracked by Wall St. Rank hold KYTH as of Q2 2015.

  • George Soros reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q2 2015 after selling out during the quarter.
  • George Soros sold 54,194 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q2 2015, an estimated $2.72M.
  • George Soros first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q1 2015 and held it in 1 quarter.
  • George Soros's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $2.72M in Q1 2015.
  • 153 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q2 2015.

Based on Soros Fund Management's 13F filing for Q2 2015, filed 14 Aug 2015.